Pharmacodynamics of julibroside J₈ and J₁₂ in inhibiting angiogenesis

1. Reynolds LP, Redmer DA. Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary. J Anim Sci. 1988; 76:1671-81.Search in Google Scholar

2. Benn SI, Whitsitt JS, Broadley KN, Nanney LB, Perkins D, He L, Patel M, Morgan JR, Swain WF, Davidson JM. Particlemediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin. J Clin Invest. 1996; 98: 2894-902.10.1172/JCI119118Search in Google Scholar

3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine. 1995; 1:27-31.10.1038/nm0195-27Search in Google Scholar

4. Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Hamid AA, Yura Y, Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol Endocrinol. 1997; 11:371-81.10.3109/09513599709152564Open DOISearch in Google Scholar

5. Epstein SE, Kornowski R, Fuchs S, Dvorak HF. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation. 2001; 104: 115-9.10.1161/01.CIR.104.1.115Search in Google Scholar

6. Zheng L, Zheng J, Zhao Y, Wang B, Wu L, Liang H. Three anti-tumor saponins from Albizia julibrissin. Bioorg Chem. 2006; 16:2765-8.10.1016/j.bmcl.2006.02.009Open DOISearch in Google Scholar

7. Liang H, Tong WY, Zhao YY, Cui JR, Tu GZ. An antitumor compound julibroside J28 from Albizia julibrissin. Bioorg Chem. 2005; 15:4493-5.10.1016/j.bmcl.2005.07.015Open DOISearch in Google Scholar

8. Zou K, Tong WY, Liang H, Cui JR, Tu GZ, Zhao YY, Zhang RY. Diastereoisomeric saponins from Albizia julibrissin. Carbohydr Res. 2005; 340:1329-34.10.1016/j.carres.2004.10.027Search in Google Scholar

9. Chen SP, Zhang RY, Ma LB, Tu GZ. Structure determination of three saponons from the stem bark of Albizzia julibrissin Durazz. Acta Pharm. Sinica. 1997; 32:110-.Search in Google Scholar

10. Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods. 2005; 37:208-15.10.1016/j.ymeth.2005.08.001Search in Google Scholar

11. Kubota Y, Kleinman HK, Martin GR, Lawley TJ. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988; 107:1589-98.10.1083/jcb.107.4.1589Search in Google Scholar

12. Soeda S, Kozako T, Iwata K, Shimeno H. Oversulfated fucoidan inhibits the basic fibroblast growth factorinduced tube formation by human umbilical vein endothelial cells: its possible mechanism of action. Biochim Biophys Acta. 2000; 1497:127-34.10.1016/S0167-4889(00)00052-5Search in Google Scholar

13. Song YS, Kim SH, Sa JH, Jin C, Lim CJ, Park EH. Antiangiogenic, Antioxidant and xanthine oxidase inhibition activities of the mushroom Phellinus linteus. J Ethnopharmacol. 2003; 88:113-6.10.1016/S0378-8741(03)00178-8Search in Google Scholar

14. Hua H, Feng L, Zhang XP, Zhang LF, Jin J. Antiangiogenic activity of julibroside J8, a natural product isolated from Albizia julibrissin. Phytomedicine. 2009; 16:703-11.10.1016/j.phymed.2009.01.00219423313Open DOISearch in Google Scholar

15. Yu DH, Qiao SY, Zhao YM. Advances in study on bark of Albizzia julibrissin, China J Chinese Materia Medica. 2004; 29;619-24.Search in Google Scholar